1. Home
  2. KEQU vs CCCC Comparison

KEQU vs CCCC Comparison

Compare KEQU & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KEQU
  • CCCC
  • Stock Information
  • Founded
  • KEQU 1906
  • CCCC 2015
  • Country
  • KEQU United States
  • CCCC United States
  • Employees
  • KEQU N/A
  • CCCC N/A
  • Industry
  • KEQU Medical Specialities
  • CCCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • KEQU Industrials
  • CCCC Health Care
  • Exchange
  • KEQU Nasdaq
  • CCCC Nasdaq
  • Market Cap
  • KEQU 106.0M
  • CCCC 104.4M
  • IPO Year
  • KEQU N/A
  • CCCC 2020
  • Fundamental
  • Price
  • KEQU $36.30
  • CCCC $1.42
  • Analyst Decision
  • KEQU
  • CCCC Buy
  • Analyst Count
  • KEQU 0
  • CCCC 3
  • Target Price
  • KEQU N/A
  • CCCC $12.00
  • AVG Volume (30 Days)
  • KEQU 5.9K
  • CCCC 989.5K
  • Earning Date
  • KEQU 06-25-2025
  • CCCC 07-31-2025
  • Dividend Yield
  • KEQU N/A
  • CCCC N/A
  • EPS Growth
  • KEQU 102.06
  • CCCC N/A
  • EPS
  • KEQU 5.90
  • CCCC N/A
  • Revenue
  • KEQU $220,026,000.00
  • CCCC $39,783,000.00
  • Revenue This Year
  • KEQU N/A
  • CCCC N/A
  • Revenue Next Year
  • KEQU N/A
  • CCCC N/A
  • P/E Ratio
  • KEQU $6.22
  • CCCC N/A
  • Revenue Growth
  • KEQU 9.44
  • CCCC 98.56
  • 52 Week Low
  • KEQU $30.33
  • CCCC $1.09
  • 52 Week High
  • KEQU $71.33
  • CCCC $7.66
  • Technical
  • Relative Strength Index (RSI)
  • KEQU 42.93
  • CCCC 45.70
  • Support Level
  • KEQU $36.36
  • CCCC $1.43
  • Resistance Level
  • KEQU $40.39
  • CCCC $1.74
  • Average True Range (ATR)
  • KEQU 1.46
  • CCCC 0.15
  • MACD
  • KEQU -0.40
  • CCCC -0.00
  • Stochastic Oscillator
  • KEQU 0.00
  • CCCC 29.41

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: